Trends & Forecast
The latest in trends & forecast for medical-aesthetics practice owners.
Trends & Forecast
The Consolidation Wave: Reading the PE Roll-Up Cycle and What It Means If You Don't Sell
Private equity is buying med spas, and the roll-up cycle reshapes your market whether or not you ever take a meeting. Understanding the cycle protects your competitive position, your staff, and your optionality.
Trends & Forecast
The Longevity Crossover: How Aesthetics Practices Are Becoming Wellness and Longevity Clinics
The line between looking better and feeling better is dissolving, and the practices extending into wellness are capturing higher-value, stickier patients, but only if they expand into it deliberately rather than by accident.
Trends & Forecast
AI in the Treatment Room: Imaging, Consult Tools, and Outcome Prediction Worth Adopting
AI is arriving in aesthetics as both genuine consult-conversion tools and overhyped vaporware. Knowing which is which — and where the patient-data and claims risks live — keeps you ahead without getting burned.
Trends & Forecast
The Regenerative Aesthetics Wave: Exosomes, PRF, Polynucleotides, and What's Real vs Hype
Regenerative is the most hyped category in aesthetics and the one with the most regulatory landmines. Separating the bookable reality from the buzz — and the legal from the risky — is an owner's job before it's an injector's.
Trends & Forecast
The Men's Aesthetics Inflection: Sizing the Segment and the Services That Actually Convert Men
Male patients are the most-cited growth segment in aesthetics and the most-fumbled. Converting them isn't about a 'men's menu.' It's about a different consult, different framing, and different reasons to walk in.
Trends & Forecast
The Year in Medical Aesthetics: An Owner's State-of-the-Industry Recap
A step back from the day-to-day to read the forces that shaped the year and carry into the next — the recurring flagship for owners who want the big picture, not just the headlines.
Trends & Forecast
Injectable Pipeline Watch: How to Read What's Heading for FDA Decisions Before It Hits Your Market
New toxins and fillers don't surprise the owners who watch the pipeline. Knowing what's coming — and reading the launch window correctly — is the difference between exploiting a new entrant and being disrupted by it.
Trends & Forecast
Korean Aesthetics Coming West: Skin Boosters, 'K-Tox,' and What US Owners Should Prepare For
Korean aesthetic trends have a habit of becoming American patient requests a year or two later. Knowing which ones are coming — and which carry a US regulatory catch — is how you lead the demand instead of scrambling to meet it.
Trends & Forecast
Polynucleotide and 'Salmon Sperm' Boosters: The Demand Curve and the US Regulatory Catch
One of the buzziest injectable categories comes with a significant regulatory question in the US. Demand is real; whether you can offer it as marketed is a different matter.
Trends & Forecast
What to Watch in Medical Aesthetics in 2026: The Shifts That Will Move Your Revenue
Not predictions — pressure points. The handful of structural shifts an owner should be positioned for before they show up in the schedule and the supply chain.
Trends & Forecast
Building a Regulatory Watch: Tracking the Scope-of-Practice and FDA Activity That Affects You
The rules governing your practice change, and the changes rarely announce themselves at your door. A simple habit of watching the right regulatory activity keeps you ahead of shifts that affect what you can do.
Trends & Forecast
At-Home and Hybrid Devices: Threat to Your Treatments or Funnel Into Them?
Consumer skincare devices keep getting better and cheaper. Whether they cannibalize your in-clinic business or feed it depends on how you position against them.
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.